The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Two women reading a guide
Friday 9 November 2018
Today, the National Institute for Health and Care Excellence (NICE) has published some draft guidance about ovarian cancer drug olaparib (Lynparza®). Their current recommendation is that olaparib should not be funded by the NHS, and this is now up for consultation. The National Institute for Health...
News
Target Ovarian Cancer supporters with Chief Executive Annwen Jones, and Members of Parliament Lee Rowley, Steve Brine, Peter Bone and Sharon Hodgson
Wednesday 31 October 2018
We asked you to help TAKE OVAR parliament... we did it! This Tuesday, MPs from across the country debated ovarian cancer in Westminster. The debate was secured by Lee Rowley MP, who spoke passionately about the need to improve early diagnosis, drawing on his own personal experience through his mum'...
News
Mother and daughter go through genetic testing
Monday 22 October 2018
In the news today: the makers of ovarian cancer drug olaparib (Lynparza®) have announced results of a clinical trial showing that the drug is effective in a new group of people - women with ovarian cancer who have a BRCA1 or BRCA2 mutation, who have just completed first-line chemotherapy. Olaparib...
Blog
Multidisciplinary centres offer GPs more diagnosis options
Thursday 18 October 2018
Rebecca Rennison, Target Ovarian Cancer’s Director of Public Affairs and Services, has been working to make sure NHS England’s new approach to speedier diagnosis works for women with ovarian cancer. She brings us an update on the multidisciplinary services, and why they must be rolled out in full...

Pages